Considering Ocular Nutritional Supplementation for Diabetes

A look at a variety of specific micronutrients and dosages that may be beneficial, and how to determine recommendations

By: A. PAUL CHOUS, MA, OD, FAAO

Optometric Management May 1, 2025 Vol (60)4, Issue May 2025 Page(s): 18,19

Clinical Report: Considering Ocular Nutritional Supplementation for Diabetes

Overview

This report examines the potential benefits of specific micronutrients in managing diabetic retinopathy (DR) and highlights the importance of addressing nutritional deficiencies in diabetic patients. It emphasizes the need for careful supplementation to avoid adverse effects on glucose monitoring.

Background

Diabetes is linked to various metabolic abnormalities that can lead to diabetic retinopathy, characterized by retinal injury and visual function deficits. Despite the importance of maintaining glycemic control, many patients do not achieve optimal levels, increasing the risk of microvascular complications. Nutritional supplementation may offer a complementary approach to managing these complications, particularly in addressing deficiencies common in diabetic patients.

Data Highlights

No specific numerical data provided in the article.

Key Findings

Vitamin C supplementation may improve islet cell function but should be limited to <500 mg/d to avoid interference with glucose monitoring.
Vitamin D levels <18.6 ng/mL are associated with proliferative diabetic retinopathy (PDR); supplementation of >5000 IU/d is recommended.
Benfotiamine (150 mg with meals) significantly reduces advanced glycation end products in type 1 diabetes patients.
Deficiencies in vitamins B1, B6, B9, and B12 correlate with higher DR incidence.
Chromium supplementation (50 mcg daily) improved HbA1c and reduced anti-VEGF injections in diabetic macular edema patients.
Higher intake of calcium, magnesium, zinc, and copper is inversely associated with DR risk.

Clinical Implications

Healthcare providers should consider assessing and addressing nutritional deficiencies in diabetic patients to potentially mitigate the risk of diabetic retinopathy. Careful supplementation, particularly of vitamins D and B, may enhance patient outcomes while ensuring that dosages do not interfere with glucose monitoring.

Conclusion

Nutritional supplementation presents a potential adjunctive strategy in managing diabetic retinopathy, but careful consideration of dosages and patient-specific factors is essential. Further research is needed to establish definitive guidelines for supplementation in this population.

PentaVision

Optometric Management